GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (XTER:MDG1) » Definitions » Pre-Tax Income

Medigene AG (XTER:MDG1) Pre-Tax Income : €-16.59 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Medigene AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Medigene AG's pretax income for the six months ended in Dec. 2023 was €-8.89 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-16.59 Mil. Medigene AG's pretax margin was -299.43%.

During the past 13 years, Medigene AG's highest Pretax Margin was -30.00%. The lowest was -354.95%. And the median was -181.74%.


Medigene AG Pre-Tax Income Historical Data

The historical data trend for Medigene AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Pre-Tax Income Chart

Medigene AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.92 -28.40 -10.28 -9.37 -16.59

Medigene AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.62 14.47 -23.85 -7.70 -8.89

Competitive Comparison of Medigene AG's Pre-Tax Income

For the Biotechnology subindustry, Medigene AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigene AG's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Medigene AG's Pre-Tax Income falls into.



Medigene AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Medigene AG's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-16.149+0+-0.548+0.135+-0.029999999999998
=-16.59

Medigene AG's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-8.776+0+-0.522+0.132+0.273
=-8.89

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-16.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medigene AG  (XTER:MDG1) Pre-Tax Income Explanation

Medigene AG's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-8.893/2.97
=-299.43%

During the past 13 years, Medigene AG's highest Pretax Margin was -30.00%. The lowest was -354.95%. And the median was -181.74%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medigene AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Medigene AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigene AG (XTER:MDG1) Business Description

Traded in Other Exchanges
Address
Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (XTER:MDG1) Headlines

No Headlines